Research location
Krnov
Czechia
Advertisement
Research activity in Krnov
CzechiaCureCurrent currently publishes aggregate city-level research activity for this location: 48 trials and 49 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Krnov
48 linked trials · page 1 of 1A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 DiabetesNCT07282600 · 2025-12-15 · 1 site observation
RECRUITING
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular DiseaseNCT07181109 · 2025-09-22 · 1 site observation
RECRUITING
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With DapagliflozinNCT06677060 · 2025-03-14 · 1 site observation
RECRUITING
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood PressureNCT06742723 · 2025-03-03 · 1 site observation
RECRUITING
A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic SyndromeNCT07219602 · 2025-12-11 · 1 site observation
ACTIVE_NOT_RECRUITING
CRF2 Agonist for the Treatment of Worsening Heart FailureNCT06815471 · 2025-08-07 · 1 site observation
SUSPENDED
A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or OverweightNCT06962280 · 2025-05-12 · 1 site observation
ACTIVE_NOT_RECRUITING
A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.NCT06268873 · 2024-03-29 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)NCT06077864 · 2023-11-20 · 1 site observation
COMPLETED
A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular RiskNCT05803421 · 2023-04-03 · 1 site observation
COMPLETED
A Study to Learn How Safe BAY2395840 is and How Well it Works in Participants Who Have Diabetic Nerve PainNCT05219812 · 2022-02-16 · 1 site observation
COMPLETED
Investigational Study of Delayed Release MetforminNCT04854512 · 2021-05-18 · 1 site observation
SUSPENDED
A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without MetforminNCT04039503 · 2019-08-30 · 1 site observation
COMPLETED
DIA_CENTRAL:T2D Treatment Pattern in Central EuropeNCT03807440 · 2019-08-26 · 1 site observation
COMPLETED
Efficacy and Safety of Sotagliflozin Versus Placebo and Empagliflozin in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking a DPP4 Inhibitor Alone or With MetforminNCT03351478 · 2017-11-27 · 1 site observation
COMPLETED
Gan & Lee Insulin Glargine Target Type (1) Evaluating ResearchNCT03371082 · 2017-10-31 · 1 site observation
COMPLETED
Efficacy and Safety of Sotagliflozin Versus Placebo in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking Insulin Alone or With Other Oral Antidiabetic AgentsNCT03285594 · 2017-09-15 · 1 site observation
COMPLETED
A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 DiabetesNCT03214380 · 2017-07-14 · 1 site observation
COMPLETED
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)NCT03071692 · 2017-03-23 · 1 site observation
TERMINATED
A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes MellitusNCT02973321 · 2016-12-02 · 1 site observation
COMPLETED
A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin MonotherapyNCT02973100 · 2016-12-01 · 1 site observation
COMPLETED
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes MellitusNCT02597049 · 2015-11-01 · 1 site observation
COMPLETED
Bexagliflozin Efficacy and Safety TrialNCT02558296 · 2015-10-01 · 1 site observation
COMPLETED
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney DiseaseNCT02540993 · 2015-09-17 · 1 site observation
COMPLETED
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney DiseaseNCT02545049 · 2015-09-17 · 1 site observation
COMPLETED
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy AloneNCT02531035 · 2015-09-01 · 1 site observation
COMPLETED
A 52-week International, Multicenter Trial With a Long -Term Extension to Evaluate Saxagliptin With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin AloneNCT02419612 · 2015-08-14 · 1 site observation
COMPLETED
Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes MellitusNCT02465515 · 2015-07-01 · 1 site observation
COMPLETED
A Study to Evaluate the Effect of Dapagliflozin on Blood Glucose Level and Renal Safety in Patients With Type 2 DiabetesNCT02413398 · 2015-06-15 · 1 site observation
COMPLETED
Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.NCT02296138 · 2015-01-13 · 1 site observation
COMPLETED
DISCOVERing Treatment Reality of Type 2 Diabetes in Real World SettingsNCT02322762 · 2014-12-30 · 1 site observation
COMPLETED
Comparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary DiseaseNCT02157935 · 2014-06-27 · 2 site observations
COMPLETED
A Study of Dulaglutide (LY2189265) in Participants With Type II DiabetesNCT02152371 · 2014-05-01 · 1 site observation
COMPLETED
A Study of LY2409021 on Blood Pressure and Pulse Rate in Participants With Type 2 Diabetes MellitusNCT02091362 · 2014-03-01 · 1 site observation
COMPLETED
A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge PatientsNCT02111564 · 2014-01-07 · 1 site observation
COMPLETED
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 DiabetesNCT02058160 · 2014-01-01 · 1 site observation
COMPLETED
Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 DiabetesNCT01864174 · 2013-06-20 · 1 site observation
COMPLETED
Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic NephropathyNCT01874431 · 2013-06-12 · 1 site observation
COMPLETED
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime InsulinNCT01499082 · 2011-12-01 · 1 site observation
COMPLETED
A Study in Participants With Type 2 Diabetes MellitusNCT01468987 · 2011-12-01 · 1 site observation
COMPLETED
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and AdolescentsNCT01444430 · 2011-12-01 · 1 site observation
COMPLETED
Utilization of Fixed Combination (Budesonide/Formoterol and Salmeterol/Fluticasone and Beclomethasone/Formoterol) in Treatment of Asthma PatientsNCT01327001 · 2011-04-01 · 1 site observation
COMPLETED
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive MedicationNCT01195662 · 2010-10-01 · 1 site observation
COMPLETED
Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents FailureNCT01117350 · 2010-07-01 · 1 site observation
COMPLETED
Effectiveness and Patient Self-assessed Compliance of Blood Pressure Treatment With Tarka® Fixed Combination in Patients With Essential HypertensionNCT01127139 · 2010-04-01 · 1 site observation
COMPLETED
Efficacy and Safety of Twice Daily 60mg AZD9668 in COPD for 12 Weeks in Patients on Background Budesonide/FormoterolNCT01023516 · 2009-11-01 · 1 site observation
COMPLETED
Effectiveness and Tolerability of Tarka® in the Treatment of Hypertensive Patients With High Risk of Developing Diabetes MellitusNCT01079195 · 2007-10-01 · 1 site observation
COMPLETED
Assessing the Impact of MOVALIS in Osteoarthritis and Rheumatoid Arthritis Patients on Health Related Quality of LifeNCT00619177 · 2007-03-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.